Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giorgio Meyn"'
Autor:
Giorgio Meyn, Søren E. Bjørn, J. Petersen, I. Jonassen, Lars Christiansen, Jens G. Litske Petersen, Jesper Skou Rasmussen, Ole Nordfang
Publikováno v:
Journal of Biological Chemistry. 268:13344-13351
Human tissue factor pathway inhibitor (TFPI) and three derivatives with deletions of: 1) the complete COOH-terminal third of the polypeptide including the third Kunitz domain, 2) the third Kunitz domain alone, or 3) the penultimate basic COOH-termina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66421bdda31d224b26ca20d8908d4dcc
https://doi.org/10.1016/s0021-9258(19)38657-0
https://doi.org/10.1016/s0021-9258(19)38657-0
Autor:
Ove Svendsen, Ulla Hedner, P. Østergaard, Claus Bregengaard, Jens G. Litske Petersen, Giorgio Meyn, Viggo Diness, Ole Nordfang
Publikováno v:
Thrombosis and Haemostasis. 70:454-457
SummaryTissue factor pathway inhibitor (TFPI) is a feed back inhibitor of the initial activation of the extrinsic pathway of coagulation. In humans, injection of heparin results in a 2-6 fold increase in plasma TFPI and recent studies suggest that TF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466b9d1441b62f99ff8bd94e33f57224
https://doi.org/10.1055/s-0038-1649604
https://doi.org/10.1055/s-0038-1649604
Autor:
Lennart Andersen, Jens Jorgen Veilgaard Brange, Eigil Schroder Rasmussen, Erik D. Laursen, Giorgio Meyn
Publikováno v:
Journal of pharmaceutical sciences. 86(5)
Formation of insulin fibrils is a physical process by which partially unfolded insulin molecules interact with each other to form linear aggregates. Shielding of hydrophobic domains is the main driving force for this process, but formation of intermo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62c18f7def7bb7ab1521d5a7aa179c75
https://pubmed.ncbi.nlm.nih.gov/9145374
https://pubmed.ncbi.nlm.nih.gov/9145374
Autor:
K. D. Jørgensen, P. Balschmidt, F. B. Hansen, I. G. Clausen, I. Jonassen, J. Petersen, E. B. Jensen, Giorgio Meyn, B. R. Johansen, B. Dath, F. Junker
Publikováno v:
Bayer AG Centenary Symposium ISBN: 9783540505068
Despite many years of clinical experimentation with commercially available short-, intermediate-, and long-acting insulin preparations, good metabolic control is still difficult to attain in a large proportion of insulin-dependent diabetics. Two basi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c59dac2b36f0f7aaa25f8bdebe12a04
https://doi.org/10.1007/978-3-642-74255-2_13
https://doi.org/10.1007/978-3-642-74255-2_13
